1430472-62-0

Basic information

• Product Name: (1R,3R,5S)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octan-3-ol
• Synonyms: (1R,3R,5S)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octan-3-ol
• CAS NO: 1430472-62-0
• Molecular Weight: 329.247
• Mol File: 1430472-62-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R,3R,5S)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octan-3-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,3R,5S)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octan-3-ol(1430472-62-0)
• EPA Substance Registry System: (1R,3R,5S)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octan-3-ol(1430472-62-0)

Safety Data

• Hazardous Substances Data: 1430472-62-0(Hazardous Substances Data)

Upstream product

• 624-38-4 para-diiodobenzene 
• 501-33-7 (1R,3R,5S)-8-azabicyclo[3.2.1]octan-3-ol 
• 1430472-15-3 (1R,3R,5S)-8-(4-iodophenyl)-8-azabicyclo[3.2.1]octan-3-ol 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 

Relevant articles and documents

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

The invention is a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).